Esperion Therapeutics | ESPR - Market Capitalization


Esperion Therapeutics reported $402.5M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Esperion Therapeutics USD 885M 351M Dec/2025
Geron USD 843M 31M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Pfizer USD 141.57B 6.48B Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024